Cargando…
Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the MK2–TEI-I01800 complex has been reported; its Gly-ric...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795553/ https://www.ncbi.nlm.nih.gov/pubmed/24121337 http://dx.doi.org/10.1107/S0909049513020736 |
_version_ | 1782287391826903040 |
---|---|
author | Fujino, Aiko Fukushima, Kei Kubota, Takaharu Kosugi, Tomomi Takimoto-Kamimura, Midori |
author_facet | Fujino, Aiko Fukushima, Kei Kubota, Takaharu Kosugi, Tomomi Takimoto-Kamimura, Midori |
author_sort | Fujino, Aiko |
collection | PubMed |
description | Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the MK2–TEI-I01800 complex has been reported; its Gly-rich loop was found to form an α-helix, not a β-sheet as has been observed for other Ser/Thr kinases. TEI-I01800 is 177-fold selective against MK2 compared with CDK2; in order to understand the inhibitory mechanism of TEI-I01800, the cyclin-dependent kinase 2 (CDK2) complex structure with TEI-I01800 was determined at 2.0 Å resolution. Interestingly, the Gly-rich loop of CDK2 formed a β-sheet that was different from that of MK2. In MK2, TEI-I01800 changed the secondary structure of the Gly-rich loop from a β-sheet to an α-helix by collision between Leu70 and a p-ethoxyphenyl group at the 7-position and bound to MK2. However, for CDK2, TEI-I01800 bound to CDK2 without this structural change and lost the interaction with the substituent at the 7-position. In summary, the results of this study suggest that the reason for the selectivity of TEI-I01800 is the favourable conformation of TEI-I01800 itself, making it suitable for binding to the α-form MK2. |
format | Online Article Text |
id | pubmed-3795553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-37955532013-10-15 Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity Fujino, Aiko Fukushima, Kei Kubota, Takaharu Kosugi, Tomomi Takimoto-Kamimura, Midori J Synchrotron Radiat Diffraction Structural Biology Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the MK2–TEI-I01800 complex has been reported; its Gly-rich loop was found to form an α-helix, not a β-sheet as has been observed for other Ser/Thr kinases. TEI-I01800 is 177-fold selective against MK2 compared with CDK2; in order to understand the inhibitory mechanism of TEI-I01800, the cyclin-dependent kinase 2 (CDK2) complex structure with TEI-I01800 was determined at 2.0 Å resolution. Interestingly, the Gly-rich loop of CDK2 formed a β-sheet that was different from that of MK2. In MK2, TEI-I01800 changed the secondary structure of the Gly-rich loop from a β-sheet to an α-helix by collision between Leu70 and a p-ethoxyphenyl group at the 7-position and bound to MK2. However, for CDK2, TEI-I01800 bound to CDK2 without this structural change and lost the interaction with the substituent at the 7-position. In summary, the results of this study suggest that the reason for the selectivity of TEI-I01800 is the favourable conformation of TEI-I01800 itself, making it suitable for binding to the α-form MK2. International Union of Crystallography 2013-11-01 2013-09-26 /pmc/articles/PMC3795553/ /pubmed/24121337 http://dx.doi.org/10.1107/S0909049513020736 Text en © Aiko Fujino et al. 2013 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Diffraction Structural Biology Fujino, Aiko Fukushima, Kei Kubota, Takaharu Kosugi, Tomomi Takimoto-Kamimura, Midori Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity |
title | Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity |
title_full | Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity |
title_fullStr | Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity |
title_full_unstemmed | Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity |
title_short | Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity |
title_sort | crystal structure of human cyclin-dependent kinase-2 complex with mk2 inhibitor tei-i01800: insight into the selectivity |
topic | Diffraction Structural Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795553/ https://www.ncbi.nlm.nih.gov/pubmed/24121337 http://dx.doi.org/10.1107/S0909049513020736 |
work_keys_str_mv | AT fujinoaiko crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity AT fukushimakei crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity AT kubotatakaharu crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity AT kosugitomomi crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity AT takimotokamimuramidori crystalstructureofhumancyclindependentkinase2complexwithmk2inhibitorteii01800insightintotheselectivity |